Showing results (151-160 of 348) with videos related to

Sort By:
Pageof 35
Blood|May 15, 1989
Response patterns of purified myeloma cells to hematopoietic growth factorsK C Anderson, R M Jones, C Morimoto, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Orbit (Amsterdam, Netherlands)|April 17, 2008
Bilateral endogenous panophthalmitis caused by Salmonella typhi: first case reportR Arora, S Das, D Chauhan, et al.
Expert Opinion on Investigational Drugs|January 5, 2002
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasiasN Mitsiades, C S Mitsiades, V Poulaki, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Advances in Orthopedics|July 24, 2013
Vacuum Assisted Closure Therapy versus Standard Wound Therapy for Open Musculoskeletal InjuriesKushagra Sinha, Vijendra D Chauhan, Rajesh Maheshwari, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|March 26, 2014
Optimized parametric skin modelling for diagnosis of skin abnormalities by combining light back-scatter and laser speckle imagingA B Orun, E Goodyer, H Seker, et al.
Orbit (Amsterdam, Netherlands)|May 19, 2007
Retrobulbar cysticercosis masquerading as optic nerve gliomaJ L Goyal, S Das, S Kumar, et al.
American Journal of Obstetrics and Gynecology|September 1, 1988
The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsiaJ Ramanathan, B M Sibai, W C Mabie, et al.
Leukemia|September 20, 2014
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibS Jagannathan, N Vad, S Vallabhapurapu, et al.
Pageof 35